Eckert & Ziegler SE (STU:EUZ)

Q2 2025 Eckert & Ziegler SE Earnings Call Transcript

Aug 8, 2025 / 10:59 AM GMT

Release Date Price: €19.7 (-8.66%)

Transcript

Key Points

Positve

Eckert & Ziegler SE (XTER:EUZ) reported a 15% growth in net sales for the medical segment, indicating strong performance in this area.
The company achieved a significant increase in profitability, with the Abbott margin rising to 24% from 22% the previous year.
There was a 20% growth in net income, despite negative currency effects, showcasing the company's resilience.
The company has expanded its executive committee, indicating a strategic focus on leadership and growth.
Eckert & Ziegler SE (XTER:EUZ) confirmed its guidance for the year, projecting sales of around 320 million and an Abbott adjusted of 78 million, reflecting confidence in meeting its targets.

Negative

The industry isotope segment showed weaker performance with only a 10% increase in sales and lower Abbott adjusted margins.
The company faced headwinds such as tariffs and security issues, which impacted sales growth.
Currency fluctuations, particularly a weak dollar, negatively affected the company's financial results.
The oil logging business was notably weak in the first half of the year, impacting overall performance.
There is a delay in the expected demand surge for certain products, such as lutetium, due to external factors affecting customer uptake.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

EUZG.DE - Eckert & Ziegler SE
Q2 2025 Eckert & Ziegler SE Earnings Call
Aug 08, 2025 / NTS GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Hello everybody. This is Harold Hasselman, the CEO of ECA and Ziegler speaking and inviting you for today's half year one results presentation of the year 2025.

Starting with a typical disclaimer that is known to everybody, I don't have to read it. Now, this is a slide, slightly adapted. Normally you see the entire executive committee, the group of directors is now enlarged. We have a fully fledged group executive committee, the three upper persons, here, Gunnaman, Frank Jaeger, and myself. Let me put in the. Laser pointer here. So these people and gentlemen are known to you, then, Joe Heathcock is also part of the American business group, so does Ana Ramirez. And then we have in our group executive committee 5 new

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.